Emergent BioSolutions
EBS
#7559
Rank
A$0.45 B
Marketcap
$8.37
Share price
7.83%
Change (1 day)
149.11%
Change (1 year)

P/E ratio for Emergent BioSolutions (EBS)

P/E ratio as of April 2025 (TTM): -0.4445

According to Emergent BioSolutions 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.444536. At the end of 2022 the company had a P/E ratio of -2.64.

P/E ratio history for Emergent BioSolutions from 2006 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-2.64-126.26%
202110.0-35.24%
202015.5-69.54%
201950.97.32%
201847.499%
201723.8-16.55%
201628.613.48%
201525.2-11.29%
201428.46.11%
201326.78.33%
201224.7-6.22%
201126.382.82%
201014.48.02%
200913.3-64.79%
200837.8490.79%
20076.41-29.41%
20069.07

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
43.8-9,959.20%๐Ÿ‡บ๐Ÿ‡ธ USA
17.1-3,936.04%๐Ÿ‡บ๐Ÿ‡ธ USA
10.7-2,509.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
-8.16 1,735.25%๐Ÿ‡บ๐Ÿ‡ธ USA
12.2-2,855.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-7.36 1,555.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-0.8105 82.31%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.